Informazione:
Errore:
ID
32713
Descrizione
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Keywords
versioni (1)
- 13/11/18 13/11/18 -
Titolare del copyright
GSK group of companies
Caricato su
13 novembre 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Estimation of Dose Proportionality of Darapladib - 107038
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Similar models
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
PGx-Pharmacogenetic Research Consent Question
Has Informed consent been obtained for PGx-Pharmacogenetic research?
Item
Has Informed consent been obtained for PGx-Pharmacogenetic research?
boolean
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
Item
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
date
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
If OTHER, specify
Item
If OTHER, specify
text
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
If YES, record date sample taken
Item
If YES, record date sample taken
boolean